The rate of discovery and approval of new medicines is declining despite substantially increased investment. Safety and efficacy failures are caused by:
The rate of discovery and approval of new medicines is declining despite substantially increased investment. Safety and efficacy failures are caused by:
|
|||||||||
|
|||||||||
|